Singapore's giant state investment company is tapping a Goldman Sachs Group Inc. veteran to help its push for more U.S. deals.

John Vaske, whose retirement from Goldman was announced Tuesday, will join Temasek in January as its head of North America.

Temasek has been rearranging responsibilities among some senior managers after Boon Sim, the firm's former president for the Americas, left the firm in May. Mr. Sim joined Temasek in 2012 from Credit Suisse Group AG, where he had been global head of mergers and acquisitions.

Temasek manages $242 billion for Singapore's government and focuses on technology and financial-services companies, which together make up about half its portfolio. It owns stakes in Chinese e-commerce giant Alibaba Group Holding Ltd., U.S. pharmaceutical Gilead Sciences Inc. and high-speed trading firm Virtu Financial Inc.

It has quietly become a player in leveraged buyouts and less-liquid investments, such as large block stakes in public companies. Earlier this year, it invested alongside private-equity firm Silver Lake in backing Dell Inc.'s $67 billion takeover of EMC Corp.

It also has been bulking up outside of Asia. North America and Europe account for 27% of its investments, up from 11% in 2013.

The firm's leadership believes there is further room to grow. Temasek plans to launch a San Francisco office to capitalize on opportunities in technology investing and grow its U.S. head count to about 50 from 30 now, people familiar with the matter said.

It has looked to big Wall Street banks in the past to build expertise in global deal making.

In 2010, it hired Greg Curl, who helped put together an acquisition spree that helped build Bank of America Corp. Other senior executives include a former Deutsche Bank AG telecom banker, a veteran of Morgan Stanley in India and Bank of America's head of investment banking for southeast Asia.

Mr. Vaske joins that group after a 28-year career at Goldman. A chemicals banker by trade, he headed the firm's natural-resources group from 2007 to 2012 and last year became one of three global co-chairs of M&A.

Write to Liz Hoffman at liz.hoffman@wsj.com and Anupreeta Das at anupreeta.das@wsj.com

 

(END) Dow Jones Newswires

October 06, 2016 12:15 ET (16:15 GMT)

Copyright (c) 2016 Dow Jones & Company, Inc.
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Gilead Sciences Charts.
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Gilead Sciences Charts.